Eiko Lifescience

{
  "main_header": {
    "sid": 1002696,
    "name": "Eiko Lifescience",
    "stock_name": "Eiko Lifescience",
    "full_name": "Eiko Lifesciences Ltd",
    "name_url": "stocks-analysis/eiko-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "51.51",
    "chg": -1.59,
    "chgp": "-2.99%",
    "dir": -1,
    "prev_price": "53.10",
    "mcapval": "78.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540204,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 5,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE666Q01016",
    "curr_date": "Jun 10, 03:30 PM",
    "curr_time": "01:25 AM",
    "last_traded_at": "Jun 10, 03:30 PM IST",
    "bse_nse_vol": "4.96 k",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eiko-lifescience-1002696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Eiko Lifesciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-eiko-lifesciences-ltd-latest-results-good-or-bad-4017433",
        "imagepath": "",
        "date": "2026-05-27 20:24:02",
        "description": "Eiko Lifesciences Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant topline growth alongside notable margin pressures. The company reported net sales of ₹18.34 crores, reflecting a robust year-on-year growth of 62.73% and a sequential increase of 53.09%. This performance marks the highest quarterly revenue in the company's history, indicating strong demand in its speciality chemicals segment.\n\nHowever, the operational metrics reveal challenges in profitability. The net profit for the quarter stood at ₹1.30 crores, which is a 23.81% increase year-on-year and a 7.44% rise quarter-on-quarter. Despite this profit growth, the operating margin (excluding other income) contracted to 12.43%, down from 15.69% in the previous quarter, raising concerns about the sustainability of this growth. The decline in margins suggests potential issues with pricing power or increase..."
      },
      {
        "title": "Eiko Lifesciences Q4 FY26: Strong Revenue Surge Masks Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/eiko-lifesciences-q4-fy26-strong-revenue-surge-masks-profitability-concerns-4015023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EikoLifescience_quaterlyResult_4015023.png",
        "date": "2026-05-26 21:05:33",
        "description": "Eiko Lifesciences Ltd., a speciality chemicals manufacturer, reported a consolidated net profit of ₹1.30 crores for Q4 FY26, marking a modest sequential increase of 7.44% from ₹1.21 crores in Q3 FY26, though significantly ahead of the ₹1.05 crores posted in Q4 FY25—a year-on-year gain of 23.81%. The micro-cap company, with a market capitalisation of ₹73.00 crores, saw its stock surge 7.39% on May 26 to close at ₹53.03, as investors responded positively to the topline momentum despite lingering concerns about profitability metrics and weak return ratios."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4013540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EikoLifescience_mojoScore_4013540.png",
        "date": "2026-05-26 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Eiko Lifesciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-eiko-lifesciences-ltd-4007446",
        "imagepath": "",
        "date": "2026-05-22 23:20:44",
        "description": "The next results date for Eiko Lifesciences Ltd is scheduled for 26 May 2026...."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-3992609",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EikoLifescience_mojoScore_3992609.png",
        "date": "2026-05-15 10:10:02",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3973255",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EikoLifescience_mojoScore_3973255.png",
        "date": "2026-05-04 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3955910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EikoLifescience_mojoScore_3955910.png",
        "date": "2026-04-21 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-3941598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EikoLifescience_mojoScore_3941598.png",
        "date": "2026-04-10 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 45.9 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/eiko-lifesciences-ltd-stock-hits-52-week-low-at-rs459-3925321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EikoLifescience_priceRelatedfactors_3925321.png",
        "date": "2026-03-30 14:27:25",
        "description": "A 30.3% decline from its 52-week high of Rs 65.9 has dragged Eiko Lifesciences Ltd to a fresh 52-week low of Rs 45.9 on 30 Mar 2026, marking a notable downturn despite recent positive earnings trends."
      }
    ],
    "total": 489,
    "sid": "1002696",
    "stock_news_url": "https://www.marketsmojo.com/news/eiko-lifesciences-1002696"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-May-2026",
      "details": "Newspaper publication dated 27th May 2026 for Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended 31st March 2026 approved by the Board at their meeting held on 26th May 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
      "datetime": "26-May-2026",
      "details": "Audited Financial Results (Standalone and Consolidated) for quarter and year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "26-May-2026",
      "details": "Re-appointment of M/s NP Rajput & Co as Internal Auditor for FY 2026-27 at the Board Meeting held on 26th May 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has declared <strong>2%</strong> dividend, ex-date: 20 Sep 17",
          "dt": "2017-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has announced <strong>2:3</strong> rights issue, ex-date: 07 Jul 23",
          "dt": "2023-07-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Are Eiko Lifesciences Ltd latest results good or bad?

2026-05-27 20:24:02

Eiko Lifesciences Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant topline growth alongside notable margin pressures. The company reported net sales of ₹18.34 crores, reflecting a robust year-on-year growth of 62.73% and a sequential increase of 53.09%. This performance marks the highest quarterly revenue in the company's history, indicating strong demand in its speciality chemicals segment. However, the operational metrics reveal challenges in profitability. The net profit for the quarter stood at ₹1.30 crores, which is a 23.81% increase year-on-year and a 7.44% rise quarter-on-quarter. Despite this profit growth, the operating margin (excluding other income) contracted to 12.43%, down from 15.69% in the previous quarter, raising concerns about the sustainability of this growth. The decline in margins suggests potential issues with pricing power or increase...

Read full news article

Eiko Lifesciences Q4 FY26: Strong Revenue Surge Masks Profitability Concerns

2026-05-26 21:05:33

Eiko Lifesciences Ltd., a speciality chemicals manufacturer, reported a consolidated net profit of ₹1.30 crores for Q4 FY26, marking a modest sequential increase of 7.44% from ₹1.21 crores in Q3 FY26, though significantly ahead of the ₹1.05 crores posted in Q4 FY25—a year-on-year gain of 23.81%. The micro-cap company, with a market capitalisation of ₹73.00 crores, saw its stock surge 7.39% on May 26 to close at ₹53.03, as investors responded positively to the topline momentum despite lingering concerns about profitability metrics and weak return ratios.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-05-26 10:10:03

Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

When is the next results date for Eiko Lifesciences Ltd?

2026-05-22 23:20:44

The next results date for Eiko Lifesciences Ltd is scheduled for 26 May 2026....

Read full news article

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-05-15 10:10:02

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-05-04 10:10:03

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-04-21 10:10:03

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-04-10 10:10:03

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 45.9 as Sell-Off Deepens

2026-03-30 14:27:25

A 30.3% decline from its 52-week high of Rs 65.9 has dragged Eiko Lifesciences Ltd to a fresh 52-week low of Rs 45.9 on 30 Mar 2026, marking a notable downturn despite recent positive earnings trends.

Read full news article

View All News